These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 8292162)

  • 1. Screening for colorectal cancer.
    Ahlquist DA; Moertel CG; McGill DB
    N Engl J Med; 1993 Oct; 329(18):1351; author reply 1353-4. PubMed ID: 8292162
    [No Abstract]   [Full Text] [Related]  

  • 2. Nonmedical costs of colorectal cancer screening with the fecal occult blood test and colonoscopy.
    Heitman SJ; Au F; Manns BJ; McGregor SE; Hilsden RJ
    Clin Gastroenterol Hepatol; 2008 Aug; 6(8):912-917.e1. PubMed ID: 18534918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for colorectal cancer.
    Brown ML
    N Engl J Med; 1993 Oct; 329(18):1352-3. PubMed ID: 8292163
    [No Abstract]   [Full Text] [Related]  

  • 4. Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer.
    Worthley DL; Smith A; Bampton PA; Cole SR; Young GP
    Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1079-83. PubMed ID: 16957514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limitations of the faecal occult blood test in screening for colorectal cancer.
    Delcò F; Sonnenberg A
    Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):119-26. PubMed ID: 10363196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for colorectal cancer: which test can we afford?
    Lansdorp-Vogelaar I; van Ballegooijen M; Kuipers EJ
    Z Gastroenterol; 2008 Apr; 46 Suppl 1():S38-40. PubMed ID: 18368641
    [No Abstract]   [Full Text] [Related]  

  • 7. 14. Appropriateness of colonoscopy: screening for colorectal cancer in asymptomatic individuals.
    Burnand B; Bochud M; Froehlich F; Dubois RW; Vader JP; Gonvers JJ
    Endoscopy; 1999 Oct; 31(8):673-83. PubMed ID: 10571142
    [No Abstract]   [Full Text] [Related]  

  • 8. Screening for colorectal cancer.
    Timins JK
    N J Med; 1997 Aug; 94(8):37-41. PubMed ID: 9265830
    [No Abstract]   [Full Text] [Related]  

  • 9. Screening for colorectal cancer with Hemoccult-II in the average risk population.
    Kronborg O
    Gastroenterol Clin Biol; 1998 Mar; 22(3 Suppl):S44-8. PubMed ID: 9762237
    [No Abstract]   [Full Text] [Related]  

  • 10. A cost analysis of screening methodology for family members of colorectal cancer patients.
    Rozen P; Ron E
    Am J Gastroenterol; 1989 Dec; 84(12):1548-51. PubMed ID: 2512809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Arguments against implementing a population-based screening programme for colorectal cancer].
    Bonneux L
    Ned Tijdschr Geneeskd; 2008 Aug; 152(32):1777. PubMed ID: 18754310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colorectal cancer screening challenges health professionals.
    Nawaz AA; Gregory DH
    Am J Gastroenterol; 2000 Oct; 95(10):2992-3. PubMed ID: 11051392
    [No Abstract]   [Full Text] [Related]  

  • 13. Judging the guidelines for colorectal cancer screening.
    Woolf SH; Ganiats TG
    Am Fam Physician; 1997 Jun; 55(8):2595, 2598-600. PubMed ID: 9191445
    [No Abstract]   [Full Text] [Related]  

  • 14. [Colorectal cancer screening: immunological test for faecal occult blood preferred].
    Jansen JB; van Rossum LG; Laheij RJ
    Ned Tijdschr Geneeskd; 2009; 153():A474. PubMed ID: 19785842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Screening colonoscopy for early detection of intestinal cancer].
    Mader U
    Dtsch Med Wochenschr; 2003 Mar; 128(12):596. PubMed ID: 12685432
    [No Abstract]   [Full Text] [Related]  

  • 16. [Preliminary report about the screening program for colorectal cancer by sequential fecal occult blood in Wuhan area for 4 years].
    Lu ZM; Chen JG; Zhang YX; Wang Q; Xu J; Chen C; Yang R; Xiong F; Liu C; Peng XH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Sep; 12(5):474-6. PubMed ID: 19742337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colorectal cancer screening: now is the time.
    Winawer SJ; Zauber AG
    CMAJ; 2000 Sep; 163(5):543-4; discussion 548. PubMed ID: 11006765
    [No Abstract]   [Full Text] [Related]  

  • 18. Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia.
    Tsoi KK; Ng SS; Leung MC; Sung JJ
    Aliment Pharmacol Ther; 2008 Aug; 28(3):353-63. PubMed ID: 18638075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential impact of population-based colorectal cancer screening in Canada.
    Flanagan WM; Le Petit C; Berthelot JM; White KJ; Coombs BA; Jones-McLean E
    Chronic Dis Can; 2003; 24(4):81-8. PubMed ID: 14733756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colorectal cancer screening in Scotland.
    Steele RJ
    Z Gastroenterol; 2008 Apr; 46 Suppl 1():S33-4. PubMed ID: 18368639
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.